Lipid Standards

Library of Glycerophospholipids Standards

Clicking on a LM_ID displays the structure in GIF (or Chemdraw) format.
Clicking on a MS/MS value (nominal mass of precursor ion) displays the fragmentation spectrum, including structures of principal product ions.
Clicking on a AVANTI_ID value displays the Avanti catalog website page.
Clicking on a CAYMAN_ID value displays the Cayman catalog website page.
Clicking on a Ref value displays a literature reference(s) pertaining to identification of fragment structures.

View LC/MS/MS protocols and retention-time data

 

Search:

  Records per page     

Fields searched:
Name, Systematic Name (case insensitive)


This table can be scrolled horizontally if width exceeds container width.

LM ID
Name
Systematic Name
Cayman ID
Avanti ID
MS/MS
Ion
Conditions
LMGP01010001 PC(12:0/13:0) 1-dodecanoyl-2-tridecanoyl-sn-glycero-3-phosphocholine LM1000 Spectrum [M.Cl]- Details
LMGP01010001 PC(12:0/13:0) 1-dodecanoyl-2-tridecanoyl-sn-glycero-3-phosphocholine LM1000 Spectrum [M+H]+ Details
LMGP02010003 PE(17:0/20:4(5Z,8Z,11Z,14Z)) 1-heptadecanoyl, 2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phosphoethanolamine LM1002 Spectrum [M-H]- Details
LMGP10010003 PA(17:0/20:4(5Z,8Z,11Z,14Z)) 1-heptadecanoyl, 2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phosphate LM1002 Spectrum [M-H]- Details
LMGP01010003 PC(17:0/20:4(5Z,8Z,11Z,14Z)) 1-heptadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phosphocholine LM1002 Spectrum [M+H]+ Details
LMGP04010006 PG(17:0/20:4(5Z,8Z,11Z,14Z)) 1-heptadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phospho-(1'-rac-glycerol) LM1002 Spectrum [M-H]- Details
LMGP01010003 PC(17:0/20:4(5Z,8Z,11Z,14Z)) 1-heptadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phosphocholine LM1002 Spectrum [M.Cl]- Details
LMGP02010003 PE(17:0/20:4(5Z,8Z,11Z,14Z)) 1-heptadecanoyl, 2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phosphoethanolamine LM1002 Spectrum [M+H]+ Details
LMGP01010004 PC(21:0/22:6(4Z,7Z,10Z,13Z,
16Z,19Z))
1-heneicosanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphocholine LM1003 Spectrum [M.Cl]- Details
LMGP01010004 PC(21:0/22:6(4Z,7Z,10Z,13Z,
16Z,19Z))
1-heneicosanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphocholine LM1003 Spectrum [M+H]+ Details
LMGP02010004 PE(21:0/22:6(4Z,7Z,10Z,13Z,
16Z,19Z))
1-heneicosanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphoethanolamine LM1003 Spectrum [M+H]+ Details
LMGP02010004 PE(21:0/22:6(4Z,7Z,10Z,13Z,
16Z,19Z))
1-heneicosanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphoethanolamine LM1003 Spectrum [M-H]- Details
LMGP01010008 PC(17:0/14:1(9Z)) 1-heptadecanoyl-2-(9Z-tetradecenoyl)-sn-glycero-3-phosphocholine LM1004 Spectrum [M.Cl]- Details
LMGP01010008 PC(17:0/14:1(9Z)) 1-heptadecanoyl-2-(9Z-tetradecenoyl)-sn-glycero-3-phosphocholine LM1004 Spectrum [M+H]+ Details
LMGP02010008 PE(12:0/13:0) 1-dodecanoyl-2-tridecanoyl-sn-glycero-3-phosphoethanolamine LM1100 Spectrum [M+H]+ Details
LMGP02010008 PE(12:0/13:0) 1-dodecanoyl-2-tridecanoyl-sn-glycero-3-phosphoethanolamine LM1100 Spectrum [M-H]- Details
LMGP02010005 PE(17:0/14:1(9Z)) 1-heptadecanoyl-2-(9Z-tetradecenoyl)-sn-glycero-3-phosphoethanolamine LM1104 Spectrum [M-H]- Details
LMGP02010005 PE(17:0/14:1(9Z)) 1-heptadecanoyl-2-(9Z-tetradecenoyl)-sn-glycero-3-phosphoethanolamine LM1104 Spectrum [M+H]+ Details
LMGP04010001 PG(12:0/13:0) 1-dodecanoyl-2-tridecanoyl-sn-glycero-3-phospho-(1'-rac-glycerol) LM1200 Spectrum [M-H]- Details
LMGP04010007 PG(17:0/14:1(9Z)) 1-heptadecanoyl-2-(9Z-tetradecenoyl)-sn-glycero-3-phospho-(1'-rac-glycerol) LM1204 Spectrum [M-H]- Details
LMGP03010001 PS(12:0/13:0) 1-dodecanoyl-2-tridecanoyl-sn-glycero-3-phosphoserine LM1300 Spectrum [M-H]- Details
LMGP03010003 PS(17:0/20:4(5Z,8Z,11Z,14Z)) 1-heptadecanoyl, 2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phosphoserine LM1302 Spectrum [M-H]- Details
LMGP03010006 PS(17:0/14:1(9Z)) 1-heptadecanoyl-2-(9Z-tetradecenoyl)-sn-glycero-3-phosphoserine LM1304 Spectrum [M-H]- Details
LMGP06010003 PI(12:0/13:0) 1-dodecanoyl-2-tridecanoyl-sn-glycero-3-phospho-(1'-myo-inositol) LM1500 Spectrum [M-H]- Details
LMGP06010004 PI(17:0/20:4(5Z,8Z,11Z,14Z)) 1-heptadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phospho-(1'-myo-inositol) LM1502 Spectrum [M-H]- Details
LMGP06010005 PI(21:0/22:6(4Z,7Z,10Z,13Z,
16Z,19Z))
1-heneicosanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phospho-(1'-myo-inositol) LM1503 Spectrum [M-H]- Details
LMGP06010006 PI(17:0/14:1(9Z)) 1-heptadecanoyl-2-(9Z-tetradecenoyl)-sn-glycero-3-phospho-(1'-myo-inositol) LM1504 Spectrum [M-H]- Details
LMGP01050001 PC(13:0/0:0) 1-tridecanoyl-sn-glycero-3-phosphocholine LM1600 Spectrum [M.Cl]- Details
LMGP01050001 PC(13:0/0:0) 1-tridecanoyl-sn-glycero-3-phosphocholine LM1600 Spectrum [M+H]+ Details
LMGP01050002 PC(17:1(10Z)/0:0) 1-(10Z-heptadecenoyl)-sn-glycero-3-phosphocholine LM1601 Spectrum [M.Cl]- Details
LMGP01050002 PC(17:1(10Z)/0:0) 1-(10Z-heptadecenoyl)-sn-glycero-3-phosphocholine LM1601 Spectrum [M+H]+ Details
LMGP10050002 PA(17:1(9Z)/0:0) 1-(9Z-heptadecenoyl)-sn-glycero-3-phosphate LM1701 Spectrum [M-H]- Details
LMGP07010002 PIP[3'](17:0/20:4(5Z,8Z,11Z,
14Z))
1-heptadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phospho-(1'-myo-inositol-3'-phosphate) LM1900 Spectrum [M-H]- Details
LMGP07010003 PIP[4'](17:0/20:4(5Z,8Z,11Z,
14Z))
1-heptadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phospho-(1'-myo-inositol-4'-phosphate) LM1901 Spectrum [M-H]- Details
LMGP07010004 PIP[5'](17:0/20:4(5Z,8Z,11Z,
14Z))
1-heptadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phospho-(1'-myo-inositol-5'-phosphate) LM1902 Spectrum [M-H]- Details
LMGP08010001 PIP2[3',4'](17:0/20:4(5Z,8Z,
11Z,14Z))
1-heptadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phospho-(1'-myo-inositol-3',4'-bisphosphate) LM1903 Spectrum [M-H]- Details
LMGP08010003 PIP2[4',5'](17:0/20:4(5Z,8Z,
11Z,14Z))
1-heptadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phospho-(1'-myo-inositol-4',5'-bisphosphate) LM1904 Spectrum [M-H]- Details
LMGP08010002 PIP2[3',5'](17:0/20:4(5Z,8Z,
11Z,14Z))
1-heptadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phospho-(1'-myo-inositol-3',5'-bisphosphate) LM1905 Spectrum [M-H]- Details
LMGP09010001 PIP3[3',4',5'](17:0/20:4(5Z,
8Z,11Z,14Z))
1-heptadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phospho-(1'-myo-inositol-3',4',5'-trisphosphate) LM1906 Spectrum [M-H]- Details
LMGP01010802 PC(18:0/20:4(5Z,8Z,11Z,14Z)) 1-octadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phosphocholine 10009864 Spectrum [M.Cl]- Details
LMGP01060010 PC(O-16:0/0:0) 1-hexadecyl-sn-glycero-3-phosphocholine 60906 Spectrum [M.Cl]- Details
LMGP01020003 PC(O-16:0/18:1(9Z)) 1-hexadecyl-2-(9Z-octadecenoyl)-sn-glycero-3-phosphocholine Spectrum [M+H]+ Details
LMGP02030003 PE(P-18:0/20:4(5Z,8Z,11Z,14Z)
)
1-(1Z-octadecenyl)-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phosphoethanolamine Spectrum [M+H]+ Details
LMGP01011222 PC(4:0/4:0) 1,2-dibutyryl-sn-glycero-3-phosphocholine Spectrum [M+H]+ Details
LMGP03010030 PS(18:1(9Z)/18:1(9Z)) 1,2-di-(9Z-octadecenoyl)-sn-glycero-3-phosphoserine Spectrum [M+H]+ Details
LMGP06050002 PI(16:0/0:0) 1-hexadecanoyl-sn-glycero-3-phospho-(1'-myo-inositol) Spectrum [M-H]- Details
LMGP02010037 PE(16:0/16:0) 1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine 15092 Spectrum [M+H]+ Details
LMGP13010004 CDP-DG(18:1(9Z)/18:1(9Z)) 1,2-di-(9Z-octadecenoyl)-sn-glycero-3-cytidine-5'-diphosphate Spectrum [M-H]- Details
LMGP02050004 PE(18:1(9Z)/0:0) 1-(9Z-octadecenoyl)-sn-glycero-3-phosphoethanolamine 25596 Spectrum [M-H]- Details
LMGP01050032 PC(18:1(9Z)/0:0) 1-(9Z-octadecenoyl)-sn-glycero-3-phosphocholine 20959 Spectrum [M+H]+ Details

Number of records: 240

next 50 records